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1. Introduction 
Recently we made the proposal and presented evi- 
dence that a noncatalytic carrier protein (sterol carrier 
protein or SCP) is involved in the conversion of squal- 
ene into cholesterol by liver microsomes [l-7]. This 
was based on observations made with an acetone pow- 
der of rat liver microsomes which required the 105,000 
g supematant (SIos) of rat liver for this conversion 
[8,91. 
We now report the following accomplishments: 
a) the purification of native SCP from unheated Slos 
of rat liver; b) when purified SCP is added to an inac- 
tive buffer-washed microsomal preparation from rat 
liver, it is capable of reconstituting the entire biosyn- 
thetic sequence from squalene to cholesterol; c) SCP 
binds not only water-insoluble precursors of choles- 
terol, but also lipid components of lipoprotein, i.e., 
cholesterol, cholesterol ester, phospholipid and 
tryglyceride; d) the amino acid composition of native 
SCP closely resembles the amino acid composition of 
the protein moiety of serum low density lipoprotein 
(LDL). These findings are compatible with the novel 
hypothesis that SCP simultaneously serves both as a 
carrier for the enzymatic synthesis of cholesterol and 
as the protein component of LDL, specifying LDL 
assembly. Thus the enzymatic synthesis by the liver 
of lipid components (e.g., cholesterol) of LDL may 
coincide with LDL assembly. 
* To whom to address correspondence. 
North-Holland Pu blishing Company - Amsterdam 
2. Materials and methods 
2.1. Substrates and materials 
Radioactive substrates were purchased from New 
England Nuclear or prepared biosynthetically for 
[” Hlsqualene [8], 4,4-dimethyl-A8 -cholesten3&ol 
and 4&methyl-A’ -cholesten3&ol [ IO]. Cy alumina 
gel was obtained from Sigma; cellulose (Whatman 
CF-11) from Reeve Angel. 
2.2. Purification of sterol carrier protein (SCP) 
The 105,OOOg supernatant (&es) of rat liver was 
perpared as previously described [8] using male 
Sprague-Dawley rats. All buffers employed during 
purification of SCP contained 1 X 1r4 M EDTA and 
1 X 1f13 M reduced glutathione; the pH was maintain- 
ed at 7.4. 
The first step in the purification of SCP from un- 
heated SOS was precipitation with buffered ammo- 
nium sulfate between 50-70% saturation; the precip- 
itate. was redissolved in 0.02 M potassium phosphate 
buffer and dialyzed against the same buffer. This solu 
tion was then applied to a C7 alumina gel-cellulose 
column ( 3 g alumina gel to 60 g of cellulose, 4 X 25 
cm). The column was eluted with 0.02 M phosphate 
buffer until no more protein was eluted (1200 ml). 
This fraction was discarded. Next a gradient (0.02- 
0.15 M phosphate buffer) was used for elution. SCP 
activity was associated with the first major protein 
peak eluted by the gradient. Since resolution from a 
second contaminating protein peak was incomplete, 
the process was repeated on a second C7 alumina gel- 
cellulose column (1 g alumina gel: 60 g cellulose, 
4 X 25 cm) with elution by a phosphate buffer gra- 
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dient (0.02-0.10 M). The protein in the fractions was 
pooled, concentrated, dialyzed, and applied to a 
Sephadex G-200 column (2 X 70 cm). In some cases 
the protein was concentrated by precipitation with 
buffered ammonium sulfate, 5%65% saturation, be- 
fore application to Sephadex G-200. The column was 
eluted with a 0.02 M phosphate buffer. The first pro- 
tein peak (elution volume approx. 150 ml) was dis- 
carded; the second protein peak (elution volume 
approx. 184 ml) contained SCP. These fractions were 
pooled, concentrated, and frozen. SCP is stable when 
frozen for a period of up to about 2 weeks, but it 
loses activity when stored for longer periods of time. 
The above purification scheme when applied to 
9.5 g of protein (400 ml Sres) yielded approx. 20 mg 
of purified SCP. 
2.3. Incubations 
Microsomes were prepared as previously described 
[8] except for the addition of a washing step using 
0.02 M phosphate buffer containing 1 X 1U4 M EDTA. 
The resulting buffer-washed microsomes were either 
used fresh of frozen in liquid nitrogen and stored at 
-80”. Incubations were conducted as previously 
described [3,8] for 2 hr at 37” under oxygen. See 
figure legends for the contents of each flask. 
Reaction products were extracted into light petro- 
leum as previously described [8]. This extract was eva- 
porated to dryness under a stream of nitrogen, 100 ~1 
of benzene added, and 15 ~1 of this solution was ap- 
plied to an Eastman Kodak silica gel sheet (1 X 20 cm). 
Elution was conducted with 1:2 chloroform: carbon 
tetrachloride. The strip was then cut into 34 segments, 
each 0.5 cm wide, and then each segment was placed 
in a scintillation vial. Toluene (10 ml) containing 0.3% 
diphenyloxazole was added to each vial, and the 
contents were shaken for 30 min. The radioactivity of 
each fraction was assayed by a Packard 3375 spectro- 
meter. 
2.4. Binding studies 
One milliliter of a solution containing SCP (after 
FRACTION NUMBER 
Fig. 1. Distribution of radioactivity on a silica-gel thin-layer chromatogram after a two-hour incubation of [3H]squalene with a 
buffer-washed rat liver microsomal preparation in the absence of added SCP. The incubation flask contained (a) microsomal sus- 
pension (0.2 ml), (b) buffer (3.8 ml), (c) NADPH and NAD dissolved in buffer ( 1 ml) to give final concentrations of 1.2 X 10e3M 
and 3 X 10e3M, respectively, and (d) [3H]squalene (44,400 cpm) added as a solution in 2:l dioxane:propylene glycol(30 ~1) [8]. 
The final concentration of microsomal protein was 1.20 mg/ml. An aliquot containing 3500 cpm was used for chromatography; 
(o-0-0) counts per minute. 
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FRKTION NUMBER 
Fig. 2. Distribution of radioactivity on a silicagel thin-layer chromatogram after a two-hour incubation of [ 3H]squalene with a 
buffer-washed rat liver microsomal preparation in the presence of added purified SCP. The incubation flask contained (a) microsomal 
suspension(0.2 ml), (b) urified SCP(2 ml), (c)buffer (1.8 ml), (d) NADPH and NAD dissolved in buffer (1 ml) to give final con- 
centrations of 1.2 X -S 10 M and 3 X 10m3 M, respectively, and (e) [ 3H]squalene (44,400 cpm) added as a solution in 2: 1 dioxane: 
propylene glycol(30 ~1). The final incubation volume was 5 ml. The final cont. of microsomal protein was 1.20 mg/ml. The final 
cont. of SCP protein was 0.53 mg/ml. This yields a SCP protein/microsomal protein ratio 0.44. Excellent conversions of squalene 
into sterol (i.e., 60%) also occurred when this ratio was equal to 0.11. An aliquot containing 3500 cpm was used for chromatography; 
(o-o-0) counts per minute. 
alumina gel purification) was used for each binding 
experiment. The radioactive substrate was added (in 
amounts of 10 nmoles or less) in 5-10 E.tl of 2: 1 
dioxane:propylene glycol [3,8] or in buffer, depend- 
ing upon solubility. Within this range the percentage 
of substrate bound for a given substrate remained 
constant. The incubation was conducted in a Dubnoff 
shaker for 15 min under nitrogen at 37”. An aliquot 
(0.05 ml) was taken for measurement of radioactivity 
and the remaining incubation contents were placed on 
a Sephadex G-25 column (2 X 25 cm); 0.02 M phos- 
phate buffer (containing 1 X l(r4 M EDTA) was the 
eluting solvent, and 3 ml fractions were collected. 
Aliquots from each fraction were assayed for radio- 
activity and protein. The radioactivity associated with 
the protein fractions constituted the protein-bound 
radioactivity. This quantity was divided by the total 
radioactivity applied to the column to yield the per- 
centage of radioactivity bound to protein. 
2.5. Amino acid analysis 
Purified SCP was hydrolyzed with redistilled 6 N 
HCl in vaccuo at 110’ for 40 hr. The resulting amino 
acids were analyzed using a Spinco Model 120C amino 
acid analyzer. 
3. Results 
3.1. Properties ofpurified native SCP 
Purification of SCP from unheated liver Slos yield- 
ed a colorless protein solution with a 280 nm/260 nm 
ratio of approx. 1.8. Polyacrylamide gel electropheresis 
at pH 7.4 yielded a single slow-moving band which 
just entered the separating gel. SCP sedimented as a 
homogeneous peak in the analytical ultracentrifuge 
with s = 3.80 S. Although SCP migrated on Sephadex 
G-200 consistent with a molecular weight of approx. 
50,000, a molecular weight determined by the menis- 
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Table 1 Table 2 
Binding of lipid components of lipoprotein and other com- 
pounds to SCP. 
Ammo acid composition of native sterol carrier protein (SCP) 
and the protein moiety of rat serum low density lipoprotein 
Compound Percentage of radioactivity 
bound to protein 
13H$qualene 78 
[ 26- 4C]Desmosterol 59 
[ lcz-3H]Cholesterol 74 
[ 1-14C]Acetate 0.9 
[ 2-3H]Mevalonate 5 
[4-14C]Testosterone 0.9 
[ 4-r4C]Estradiol 0.3 
[ 1 ,2-3H]Cortisol 21 
[ 1-r4C]Triolein 78 
[ 1,2-‘4C]Phosphatidylcholine 84 
Cholesteryl-jj-3H]oleate 69 
Palmitylj I- C]CoA 99 
[ l-14C]Oleic acid 72 
[ 14C]D-glucose 0 
[2-‘4C]Glycerol* 0 
L-[ 14C]glycerol -phosphate 1.1 
(LDL). 
- 
SCP LDL protein [ 141 
(moles/lo3 moles of amino acids) 
* Binding experiments were preformed with the substrate ad- 
ded in either buffer or 2: 1 dioxane:propyleneglycol. 
cus depletion sedimentation equilibrium method [ 1 l] 
gave a value of 28,000. 
Lys 87.7 88.5 
HiS 16.2 19.4 
Arg 50.5 54.0 
Asp 105.2 100.0 
Thr 56.2 58.3 
Ser 69.8 77.2 
Glu 116.5 130.0 
Pro 59.6 37.8 
Gly 65.9 49.1 
Ala 67.3 62.6 
Val 68.0 55.6 
Be 53.0 45.2 
Leu 105.2 118.0 
Tyr 28.0 26.1 
Phe 49.8 45.4 
Met + 23.3 
L/2 cys + tr 
Try + 8.5 
+: The amino acid was detected, but suitable quantitative 
data is not yet available; tr: Trace. 
Lipid analysis of purified SCP by thin-layer 
chromatography showed only trace amounts of 
endogenous lipid (less than 1% of the protein mass). 
Lipids detected at this level induced free fatty acid, 
triglyceride, cholesterol and phospholipid. These 
results confirmed our earlier finding that SCP does 
not float in the ultracentrifuge at densities (1.21) 
which float lipoportein [ 121. 
3.2. Biological activity of purified SCP 
Fig. 1 shows a silicic acid chromatogram from a 
control experiment in which a buffer-washed rat liver 
microsomal preparation was incubated with 
[3H]squalene in the absence of added SCP. The sub- 
strate [jH]squalene, appears in fractions 27-34; a 
small product peak is seen in the 27-carbon-atom 
sterol region (fraction 3). Only a 7% conversion of 
squalene into sterols occurred in this experiment, 
with 3.5% of the recovered radioactivity present in 
the 27-carbon-atom sterol region. 
the addition of purified SCP. The following points 
should be noted: a) When SCP is added there is a 
tremendous increase in the size of the 27-carbon-atom 
sterol peak (fractions 4-6); approx. 50% of the 
recovered radioactivity is associated with this peak. 
This represents an approx. 15fold stimulation when 
compared with the control (fig. 1). In several experi- 
ments similar to the one shown in fig. 2, the amount 
of radioactive cholesterol in this peak has varied from 
20 to 50% as demonstrated by passage through the 
dibromide [ 131. b) Note the much smaller squalene 
peak (fractions 27-3 1) in fig. 2. c) Several small peaks 
which represent intermediates in the conversion of 
squalene into cholesterol are seen. d) The overall con- 
version of squalene into sterol in this experiment was 
73%, compared to 7% in the absence of added SCP. 
3.3. Binding studies 
Fig. 2 shows a silicic acid chromatogram of an 
experiment exactly the same as in fig. 1 except for 
Table 1 shows the results obtained in binding experi- 
ments of SCP with several compounds. The following 
conclusions can be made: a) Cholesterol and its 
water-insoluble precursors (e.g., squalene and 
230 
Volume 25, number 2 FEBS LETTERS September 1972 
desmosterol) show significant binding to SCP. We 
have also demonstrated binding to SCP of several 
other cholesterol precursors not shown in table 1, e.g., 
squalene-2,3-oxide-3H, 4,4-dimethyl-Aa cholesten- 
3&0l-~H and 4f3-methyl-A*-cholesten-3f3-ol-3H. b) The 
two water-soluble precursors of cholesterol studied 
(acetate and mevalonate) did not show significant 
binding to SCP. c) There is a high specificity of SCP 
towards steroid structure in that [4-14C]testosterone 
and [4-r4C]estradiol were not bound appreciably 
(less than 1% bound) and cortisol was only slightly 
bound. d) Lipid components of lipoprotein, e.g., tri- 
glyceride (triolein), phospholipid (phosphatidyl- 
choline), and cholesterol ester (cholesteryl oleate) 
showed a high affinity for SCP. In addition, palmityl 
CoA and oleic acid were bound in high yield. e) 
Radioactive glycerol, glycerol phosphate, and glucose 
did not bind significantly to SCP. 
3.4. Amino acid analysis of SCP 
The amino acid composition of purified SCP is 
shown in table 2. For comparison the amino acid 
composition of the protein moiety of serum low 
density lipoprotein (LDL) from male Sprague-Dawley 
rats as determined by Koga et al. [14] is also shown. 
A good correlation exists between SCP and LDL 
protein for lysine, histidine, arginine, aspartic acid, 
threonine, serine, glutamic acid, alanine, isoleucine, 
leucine, tyrosine and phenylalanine. The SCP values for 
proline, glycine and valine are somewhat higher than 
the corresponding values for LDL protein. This may 
be caused by a minor impurity in SCP. Overall, how- 
ever, the amino acid composition of native SCP is 
very similar to the amino acid composition of rat 
serum LDL protein. 
4. Discussion 
In the present work we have described the purifi- 
cation of native SCP from unheated S,,,. As we have 
shown previously [3] , SCP incubated alone with 
[3H]squalene is inert since chemically unchanged 
substrate is recovered. However, when purified SCP 
is added to an inactive buffer-washed microsomal 
preparation from rat liver, we have shown for the 
first time that it is capable of reconstituting the entire 
biosynthetic sequence from squalene to cholesterol. 
We have also achieved successful reconstitution by 
adding purified SCP to buffer-washed acetone powders 
of rat liver microsomes. 
Furthermore, SCP binds not only water-soluble 
precursors of cholesterol but also lipid components 
of lipoprotein, i.e., cholesterol, cholesterol ester, 
phospholipid and triglyceride. In addition, the amino 
acid composition of SCP (table 2) is very similar to 
the amino acid composition of the protein moiety of 
serum low density lipoprotein [ 141. A further examin- 
ation of the work of Koga et al. [ 141 shows that the 
ammo acid compositions of serum very low density 
lipoprotein (VLDL) and high density lipoprotein 
(HDL) from the rat do not correspond to the amino 
acid composition of SCP. In a more recent study [ 151, 
Scanu and co-workers examined subunit polypeptides 
from rat serum lipoproteins. Again the amino acid 
composition of SCP is very similar to their P I low 
density apolipoprotein which is the predominant 
(70%) and distinctive component of low density ape- 
lipoprotein [ 15]*. The amino acid compositions of 
HDL peptides were not consistent with the amino acid 
composition of native SCP. 
These fmdings are compatible with the novel 
hypothesis that SCP simultaneously serves both as a 
carrier for the enzymatic synthesis of cholesterol and 
as the protein component of LDL, specifying LDL 
assembly. Thus the enzymatic synthesis by the liver 
of lipid components (e.g., cholesterol) of LDL may 
coincide with LDL assembly. It is interesting to note 
that the half-life in man for the protein moiety of LDL 
has been reported to be approx. 3.5 days [ 161. The 
half-life for cholesterol in Pool A (which includes 
serum and liver cholesterol) has been reported to be 
3-4 days [ 171 . The similar half-lives for cholesterol 
and LDL protein are consistent with our hypothesis. 
Also, in preliminary experiments [ 181 we have been 
able to detect native SCP only in the liver. SCP could not 
be detected in brain, adrenal, kidney, lung, intestine or 
spleen. Shah [19] also could not detect SCPin the brain. 
These observations are also consistent with the above 
hypothesis since the liver is the principal organ 
responsible for serum LDL synthesis, while the lung, 
brain, adrenal, kidney and spleen do not synthesize 
serum LDL. Also, it seems logical that the enzymatic 
* The P I apolipoprotein is also present in VLDL, where it 
constitutes 25-40% of VLDL protein [ 151. 
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conversion of squalene into cholesterol should occur 
with intermediates and final product (cholesterol) 
bound to LDL protein since it has been shown that 
serum LDL carriers 70% of the plasma cholesterol 
1201. 
Certain aspects of the disease abetalipoproteinemia 
[21-251 may be explained by the hypothesis pro- 
posed here. In this condition serum cholesterol con- 
centrations are characteristically very low (e.g., 
30-50 mg per 100 ml of serum compared with the 
normal range of 150-250 mg per 100 ml of serum) 
[21-241. It is thought that the protein component 
of LDL is either absent [21,22] or not functional 
[23-251 in these individuals. Our hypothesis would 
suggest hat these individuals may have a marked 
decrease in cholesterol synthesis by the liver due to 
absent or defective SCP (LDL protein). This could be a 
major cause for the observed low serum cholesterol 
concentration. 
Vagelos and co-workers [26] have described the 
requirement for an acyl carrier protein (ACP) in the 
biosynthesis of fatty acids. There appear to be 
distinct differences between the roles of ACP and SCP: 
i) ACP forms a covalent thioester bond while acting 
as a carrier in fatty acid synthesis. SCP, however, does 
not form a covalent link, but is held to the substrate 
by hydrophobic forces. ii) ACP is regenerated after 
the synthesis of palmitic acid. Our experiments indi- 
cate, however, that SCP is not regenerated after the 
appearance of cholesterol, but instead cholesterol 
remains bound to SCP and causes it to aggregate and 
migrate as a lipoprotein on Sephadex G-200 [5] . Thus 
if SCP serves both as a carrier during cholesterol 
synthesis, and as the protein component of LDL, 
specifying LDL assembly, then the biological role of 
SCP would be very different from the role of ACPin 
fatty acid synthesis. The whole process of LDL 
assembly could occur in a multi-enzyme complex in 
the endoplasmic reticulum of liver, for which we 
suggest he name lipoprotein synthetase. Viewed in this 
context SCP would be both a carrier in cholesterol 
synthesis and a substrate in LDL assembly by the liver. 
In recent preliminary communications [27-291 
Ritter and Dempsey have reported the purification 
of a heat-stable peptide isolated after heating Sres to 
100” for 5 min. They believe that this peptide is SCP 
[28, 291, based on stimulation of the conversion of 
7-dehydrocholesterol into cholesterol. They also 
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report that this reaction is stimulated by a peptide, 
R-Gin-II, which was isolated from lipid-extracted high 
density lipoprotein. It was necessary in both cases to 
preincubate the sterol substrate with the peptide, in 
order to obtain stimulation of the conversion of 
7-dehydrocholesterol into cholesterol. These results 
are in marked contrast to our consistent demonstra- 
tion that native SCP is heat-labile, either in crude 
extracts or in the purified state [3,7,30]. Other in- 
vestigators have also noted that the ability of S,,, to 
stimulate various reactions in cholesterol biosynthesis 
is destroyed by heating [31,32] . Also, we have been 
unable to detect the peptide isolated by Ritter and 
Dempsey in unheated Sr,,s [7]. Thus the origin of this 
peptide is in doubt. Recent preliminary observations 
in our laboratory [30] suggest hat the peptide isolated 
by Ritter and Dempsey after heating S ies does not 
originate from native SCP at all, but instead originates 
from breakdown of a protein fraction which has no 
SCP activity prior to heating. Another difference is 
that native SCP does not require preincubation with 
substrate (in fact, preincubation is inhibitory) either 
in crude or purified form. 
In any event the amino acid composition, electro- 
phoretic mobility, heat lability, and lack of a require- 
ment for preincubation all indicate that native SCP 
isolated from unheated S,,,, as reported here, is 
clearly a different protein than the material isolated 
by Ritter and Dempsey. We conclude that the protein 
isolated as described in the present report represents 
the protein which operates physiologically. 
If SCP is the protein component of LDL, then our 
isolation of this protein is, to the best of our knowledge, 
the first isolation and characterization of a protein 
component of lipoprotein before the attachment of 
lipid. Because of the absence of lipid, very gentle 
techniques of protein purification can be employed, 
thus facilitating studies concerned with the biological 
activity and quaternary structure of this protein. This 
is a considerable advantage since methods used for the 
isolation of the protein moieties of serum lipoproteins 
presently depend on rigorous solvent extraction along 
with the use of substances uch as 8 M urea to prevent 
aggregation [151 .
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